BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15735924)

  • 1. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
    J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.
    Combs SE; Gutwein S; Thilmann Ch; Huber P; Debus J; Schulz-Ertner D
    J Neurooncol; 2005 Sep; 74(2):167-71. PubMed ID: 16193388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of radiotherapy in recurrent gliomas].
    Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
    Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
    Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
    J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability.
    Combs SE; Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Gempt J; Meyer B
    Neurosurgery; 2018 Dec; 83(6):1241-1248. PubMed ID: 29462372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT).
    Combs SE; Thilmann C; Debus J; Schulz-Ertner D
    BMC Cancer; 2006 Sep; 6():222. PubMed ID: 16959039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
    Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
    J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
    Lee J; Cho J; Chang JH; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
    Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.
    Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J
    Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
    Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
    Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy.
    Voynov G; Kaufman S; Hong T; Pinkerton A; Simon R; Dowsett R
    Am J Clin Oncol; 2002 Dec; 25(6):606-11. PubMed ID: 12478010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
    Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
    J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.